At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...
Candidates applying for the Senior Executive posts must hold an MSc in Physics, Chemistry, or other sciences, or a B.Tech, B.E., or MCA degree from a recognised university or institute ...